Teva Can't End Inhaler Antitrust Suit But Gets Claim Nixed

By Matthew Perlman · November 7, 2024, 5:19 PM EST

A Massachusetts federal court refused Teva Pharmaceutical Industries Ltd.'s attempt to end a case accusing it of orchestrating a decade-long scheme to delay generic competition for its QVAR asthma inhalers, but...

To view the full article, register now.